📩 Daily Stock Watchlist – 08/11/2025

August 11, 2025

Hello Investor,

Here’s your sneak peak daily stock watchlist with key insights to help guide your investment decisions.

Today’s report includes market trends, upcoming catalysts, and under-the-radar stocks with strong medium-to-long-term potential.

Want to supercharge your portfolio with alpha like this, daily? Upgrade for less than your morning Starbucks order.

Now let’s dive in.

🌐 Market Overview

Major Indices:

  • S&P 500 (SPY): +0.78% at 637.18

  • NASDAQ-100 (QQQ): +0.94% at 574.55

  • Dow Jones (DIA): +0.65% at 459.82

Strength led by AI infrastructure, semiconductors, and select industrials.

Sector Rotation:

AI/data center themes, cement, metals, and pharmaceuticals outperform; financials and consumer discretionary lag.

Macroeconomic Factors:

Investor sentiment lifted by easing inflation trends and expectations for a gradual Fed stance. July CPI due later this week could validate disinflation narrative.

🔍 Top 5 Stocks to Watch

🧬 Zai Lab (ZLAB)

Investment Thesis: China-based biotech with multiple approved oncology and immunology products, on track for profitability in late 2025.

  • Accumulation Zone: $32–$36

  • Target: $48–$52 in 6–12 months

  • Risks: China regulatory changes, currency headwinds

  • Catalysts: 80% projected revenue growth over the next year, key trial readouts expected in Q4.

🖥 VNET Group (VNET)

Investment Thesis: Chinese data center operator capitalizing on surging AI/cloud infrastructure demand from major tech players.

  • Accumulation Zone: $7.40–$8.20

  • Target: $12–$13 in 3–6 months

  • Risks: ADR structure, geopolitical uncertainty

  • Catalysts: Contract wins in Tier 1 markets; strong earnings guidance expected this quarter.

🏗 Sterling Infrastructure (STRL)

Investment Thesis: Builds and upgrades mission-critical data centers; benefiting from AI-driven construction demand.

  • Accumulation Zone: $290–$305

  • Target: $360–$380 in 6–12 months

  • Risks: Contract delays, cyclical construction slowdowns

  • Catalysts: Record backlog and margin expansion tied to high-spec AI facility projects.

⚙ Argan Inc. (AGX)

Investment Thesis: Specialty engineering company in renewable energy, power, and data-center builds with strong balance sheet.

  • Accumulation Zone: $230–$245

  • Target: $270–$290 in 3–6 months

  • Risks: Project revenue lumpiness

  • Catalysts: Accelerating renewable and infrastructure contracts; potential for special dividend.

🚢 ZIM Integrated Shipping (ZIM)

Investment Thesis: Global shipping firm trading at a deep value multiple; positioned for freight rate rebound.

  • Accumulation Zone: $14.50–$16.00

  • Target: $22–$24 in 6–12 months

  • Risks: Cyclical shipping market, fuel cost volatility

  • Catalysts: Stabilizing freight rates, operational cost reductions, and potential shareholder returns.

🏛 Institutional & Insider Activity

  • ZLAB: Hedge fund accumulation ahead of late-stage trial data.

  • VNET: Steady institutional buying into Q2 earnings.

  • STRL: Multiple insider purchases over past 60 days.

  • AGX: Dividend-focused funds increasing exposure.

  • ZIM: Value investors re-establishing positions at cycle lows.

🎯 Actionable Investing Strategies

  • Portfolio Exposure: Allocate 10–15% toward high-conviction small/mid-cap growth opportunities with clear catalysts.

  • Risk Management: Use staged entries within accumulation zones; trim positions if fundamentals shift or targets are met early.

  • Thematic Tilt: Blend AI/data center infrastructure (VNET, STRL, AGX) with defensive biotech growth (ZLAB) and cyclical recovery (ZIM).

📅 Earnings & Events to Watch

  • ZLAB: Q2 earnings late August; oncology trial results in Q4.

  • VNET: Q2 earnings in ~2 weeks; guidance closely watched.

  • STRL: Early September earnings; backlog/margin commentary key.

  • AGX: Late August earnings; potential capital return update.

  • ZIM: Q2 earnings this week; freight rate outlook in focus.

  • Macro: July CPI report Thursday; Fed minutes next week.

—StocksTrades.AI Newsletter

P.S. Supercharge your portfolio with alpha like this, daily? Upgrade for less than your morning Starbucks order.

Disclaimer: This newsletter is for informational purposes only and does not constitute financial advice. Always conduct your own research before making investment decisions.